Psychedelics – News and Features
News
Xceleron Receives the Award for International Achievement at Yorkshire Bioscience Awards
Xceleron was recognized for its recent achievements overseas following the establishment of its subsidiary in the US.
News
Xceleron Leads EU Microdose AMS Partnership Programme
The programme aims to certify AMS technologies as appropriate methodologies for measurements required by microdosing studies.
News
Xceleron and Servier Sign Agreement to Accelerate Drug Development
The Agreement covers the provision by Xceleron of accelerator mass spectrometry services to assist Servier.
News
Xceleron Signs Three Year Preferred Supplier Agreement With GSK
Xceleron will provide support for GSK's bioanalytical AMS programme.
Advertisement
